ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01856868
Recruitment Status : Recruiting
First Posted : May 17, 2013
Last Update Posted : March 14, 2017
Sponsor:
Collaborator:
Cardero Therapeutics, Inc.
Information provided by (Responsible Party):
Craig McDonald, MD, University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2018
  Estimated Study Completion Date : July 2018